PAK5/6 (phospho Ser602/S560) Polyclonal Antibody

货号：ES6872
价格：面议
点击：2387

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Mouse
别称	PAK7; KIAA1264; PAK5; Serine/threonine-protein kinase PAK 7; p21-activated kinase 5; PAK-5; p21-activated kinase 7; PAK-7; PAK6; PAK5; Serine/threonine-protein kinase PAK 6; PAK-5; p21-activated kinase 6; PAK-6

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	319
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	432
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	279
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	408
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	272
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	372
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	141
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	217
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	151
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	363
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	447
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	282
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	290
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	449
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	507
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	292
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	148
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	483
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	359
Anti-Certolizumab Neutralizing Recombinant Antibody \|抗赛妥珠单抗中和重组抗体(靶标：赛妥珠单抗中和抗体)	161